Want to see HK:9886 full AI Analyst Report?
9886 Stock Chart & Stats
HK$0.81
HK$0.00(0.00%)
At close: 4:00 PM EDT
HK$0.81
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.66 - HK$1.37
Previous CloseN/A
Volume21.50K
Average Volume (3M)4.91M
Market Cap
HK$976.17M
Enterprise ValueHK$199.57
Total Cash (Recent Filing)HK$1.12B
Total Debt (Recent Filing)HK$281.81M
Price to Earnings (P/E)―
Beta1.60
Next Earnings
Mar 31, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding1,240,312,900
10 Day Avg. Volume8,114,443
30 Day Avg. Volume4,906,414
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)0.75
Price to Sales (P/S)0.26
P/FCF Ratio10.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-1.35
Revenue Forecast (FY)HK$126.42B
Bulls Say, Bears Say
Bulls Say
Revenue And Margin RecoveryThe sharp rebound in revenue and improving gross margin indicate stronger demand and better operating economics. If sustained, this combination can improve scalability and provide a foundation for the online-to-offline pharmacy model to approach profitability.
Positive Operating And Free Cash FlowThe return to positive operating and free cash flow improves financial flexibility and reduces reliance on external funding. It also suggests the pharmacy and healthcare platform generated cash from operations during the latest reporting period.
Manageable Current LeverageLow recent leverage and positive equity provide a stronger funding base for maintaining the pharmacy network and digital fulfillment infrastructure. This balance-sheet position should help the company absorb operating volatility without excessive debt-service pressure.
Bears Say
Business Remains UnprofitableDespite substantial improvement, the company has not yet demonstrated sustainable earnings profitability. Continued losses limit internally generated capital, make results more sensitive to execution, and leave the business dependent on further margin improvement.
Cash Flow Durability Remains UnprovenThe latest cash-flow turnaround is encouraging but follows several years of negative generation. Because 2025 cash conversion occurred while net income remained slightly negative, working-capital or non-cash effects may mean the improvement is not yet fully durable.
Historical Balance-Sheet StressRecent leverage is manageable, but the earlier period of negative equity and high debt demonstrates meaningful historical financial stress. This record raises longer-term execution and resilience concerns if growth weakens or profitability improvement stalls.
Dingdang Health Technology Group Ltd. News
9886 FAQ
What was Dingdang Health Technology Group Ltd.’s price range in the past 12 months?
Dingdang Health Technology Group Ltd. lowest stock price was HK$0.66 and its highest was HK$1.37 in the past 12 months.
What is Dingdang Health Technology Group Ltd.’s market cap?
Dingdang Health Technology Group Ltd.’s market cap is HK$976.17M.
When is Dingdang Health Technology Group Ltd.’s upcoming earnings report date?
Dingdang Health Technology Group Ltd.’s upcoming earnings report date is Mar 31, 2027 which is in 216 days.
How were Dingdang Health Technology Group Ltd.’s earnings last quarter?
Dingdang Health Technology Group Ltd. released its earnings results on Aug 21, 2026. The company reported -HK$0.058 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Dingdang Health Technology Group Ltd. overvalued?
According to Wall Street analysts Dingdang Health Technology Group Ltd.’s price is currently Overvalued.
Does Dingdang Health Technology Group Ltd. pay dividends?
Dingdang Health Technology Group Ltd. does not currently pay dividends.
What is Dingdang Health Technology Group Ltd.’s EPS estimate?
Dingdang Health Technology Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dingdang Health Technology Group Ltd. have?
Dingdang Health Technology Group Ltd. has 1,240,312,900 shares outstanding.
What happened to Dingdang Health Technology Group Ltd.’s price movement after its last earnings report?
Dingdang Health Technology Group Ltd. reported an EPS of -HK$0.058 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.5%.
Which hedge fund is a major shareholder of Dingdang Health Technology Group Ltd.?
Currently, no hedge funds are holding shares in HK:9886
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dingdang Health Technology Group Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
80.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
12.67%
Trailing 12-Months
Company Description
Dingdang Health Technology Group Ltd.
Dingdang Health Technology Group Ltd. is a digital retail pharmacy firm operating within the People's Republic of China. The company provides online sales of pharmaceutical products alongside medical consultation services. Founded in 2014, it is based in Beijing, China.
Technical Analysis
Innovative Pharmaceutical Biotech
―
Natural Beauty Bio-Technology
―
Cheerwin Group Limited
―
EC Healthcare
―
Giant Biogene Holding Co. Ltd.
―